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Alzheimer’s disease     AD 
Angiotensin       Ang  
Angiotensin converting enzyme 2  ACE2 
Bradykinin receptors 1 and 2   B1R, B2R 
Brain-derived neurotrophic factor   BDNF 
Bromodeoxyuridine     BrdU 
Central nervous system     CNS 
Dentate gyrus      DG 
Electroconvulsive (seizure) therapy   ECS, ECT 
Induced pluripotent stem cell    iPSC 
Neural stem cell     NSC 
Renin-angiotensin system    RAS 
Selective serotonin reuptake enhancer  SSRE 
Selective serotonin reuptake inhibitor  SSRI 
Serotonin      (5-hydroxytryptamine, 5-HT) 
Serotonin transporter     SERT (5-HTT, SLC6A4) 
SRY-related HMG-box gene 2     Sox2 
Subgranular zone     SGZ 
Tryptophan       Trp 
Tryptophan hydroxylase 2    TPH2 
 







The adult brain is highly plastic. Its structure is able to adapt to environmental challenges 
and novel experiences by rewiring upon learning, and responds to trauma or injury. The brain’s 
‘neuroplasticity’ comprises alterations in synaptic structure, strengthening or weakening 
synaptic connections, but also the generation of new neurons and creation of new neural 
connections. Specifically, the discovery that new neurons are continuously generated 
throughout life has stirred hope for new therapeutic strategies to improve cognitive function and 
to treat neurodegenerative disorders.  
 
 
1.1. From Stem Cells to Signaling Pathways Regulating Adult Neurogenesis    
The dentate gyrus (DG) of the hippocampus is one of the two prominent regions in the 
mammalian brain where ‘adult neurogenesis’ persists throughout life (Altman and Das, 1965; 
Kaplan and Hinds, 1977). As part of the limbic system, the hippocampus plays a central role in 
learning, especially in the encoding and retrieval of episodic and spatial memories (Buzsaki and 
Moser, 2013). While synaptic plasticity and dendrite complexity, GABA and cholinergic tone 
drive the neural circuit of memory formation (Buzsaki, 1989; Hasselmo, 1999), continued neuron 
generation might also contribute to learning, and adding new neurons might lead to optimizing 
a running system upon environmental need (Kempermann, 2002). The neurogenic niche of the 
DG, the subgranular zone (SGZ), accommodates neural stem cell (NSC) populations (type-1 
cells) that give rise to proliferating amplified progenitor cells (type-2a/b, type-3) that become 
immature and mature neurons (Kempermann et al, 2004) in a time-specific manner (Plumpe et 
al, 2006; van Praag et al, 2002). The progression is regulated dynamically within a defined 
microenvironment that is primed to support a neuronal fate. Surrounded by vasculature and in 
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close proximity to glial cells, neural stem/progenitor cells retain fate plasticity and respond to a 
variety of local cues and extrinsic stimuli that promote neurogenesis. 
 
Among the neurogenic niche’s intrinsic components are cell-autonomous molecules and 
extracellular signaling proteins, growth and transcription factors that differ in their effects on 
stem cell maintenance, cell proliferation and differentiation, cell death and survival (reviewed in 
Goncalves et al, 2016). To regulate the distinct stages of adult neurogenesis, coordinated and 
cell type-specific gene transcription is required. Sox2 (SRY-related HMG-box gene 2) is a 
prominent regulator that controls multipotency and fate choice of type-1 and type-2 precursor 
cells (Steiner et al, 2006). In concert with lineage instruction factors, pathways driven by 
serotonin or neurotrophic signaling, e.g. brain-derived neurotrophic factor (BDNF) signaling, are 
key regulators to maintain neurogenesis. While serotonin modulates both proliferation and 
survival of newly generated cells (reviewed in Alenina and Klempin, 2015), BDNF is crucially 
involved in neuronal maturation and synaptic plasticity (Ferres-Coy et al, 2013; Mattson et al, 
2004). Alongside local cues, novel experiences influence stem/progenitor cell behavior in 
rodents, and activity-dependent changes in neuroplasticity occur; including increased precursor 
cell proliferation upon physical exercise (Kronenberg et al, 2003; van Praag et al, 1999) and cell 
survival upon exposure to an enriched environment (Kempermann and Gage, 1999). Thereby, 
the various growth and neurotrophic factors participate in the experience-dependent effects on 
neurogenesis (Woost et al, 2018).   
 
Neuroplasticity of the adult brain can also be negatively regulated; inducing structural 
changes that can be studied in the diseased brain. Impaired neurogenesis has been observed 
in stress-related events and is associated with age-related cognitive decline, neurodegenerative 
and psychiatric disorders in humans (e.g. Alzheimer’s disease (AD), temporal lobe epilepsy, 
major depression), and obesity. Whether neuron loss is causative or associative with the 
pathologies still needs to be shown. Nevertheless, many of the intrinsic factors of the neurogenic 
niche also appear to be altered in disease. In the case of major depression, manipulations 
modulating extracellular serotonin levels lead to clinical improvement that is linked to a delayed 
increase in adult neurogenesis as shown in rodents (Malberg et al, 2000; Santarelli et al, 2003). 
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Furthermore, low serum BDNF levels have been observed in depressed patients that can be 
replenished by antidepressant treatment (Molendijk et al, 2011). While neuron replacement is 
the desired strategy to repair the diseased brain, targeting of signaling factors that support 
neuronal development is a potential therapeutic alternative.  
 
Identifying serotonin’s contribution to brain plasticity in health and disease has been a 
unifying component of my research career. Dysregulation of serotonin signaling is associated 
with neurogenic decline, age-related memory loss and mood disorders, but also impacts 
homeostatic systems that control satiety, energy metabolism and stress responses (reviewed 
in Donovan and Tecott, 2013). Serotonin is the most widespread monoamine of the central 
nervous system (CNS) with fiber pathways projecting into numerous brain areas and spinal 
cord. Target areas in the DG express various 5-HT receptors that control the response from 
efferent activity (Brezun and Daszuta, 2000; Klempin et al, 2010). Serotonin mediates a variety 
of functions but is particularly known for conveying a sense of contentment and happiness. 
Serotonin-based antidepressants are used with the immediate action to alter the synaptic 
availability of the monoamine, targeting serotonin transporter and 5-HT (auto-)receptors 
(reviewed in Descarries and Riad, 2012). ‘State of the art’ therapy consists of selective serotonin 
reuptake inhibitors (SSRIs) or, somewhat paradoxically, also SSR-enhancers (SSREs). 
Although SSRI-mode of action is an acute facilitation of serotonin transmission, only chronic 
treatment leads to clinical improvement accompanied by increased cell proliferation and 
generation of new neurons in the DG (Encinas et al, 2006; Klempin et al, 2010; Malberg et al, 
2000). However, a fairly large number of patients do not respond to treatment. Lack of 
understanding a clear mechanism of SSRI function significantly limits our ability to effectively 
manage depression.  
 
Several approaches developed in animal models, e.g. acute depletion, or 5-HT receptor 
targeting (Brezun and Daszuta, 2000; Diaz et al, 2013; Klempin et al, 2010) have already been 
used in the clinics and vice versa. Recent genetically modified models that differ in their 
availability of serotonin, constitute new powerful tools to study neuroplasticity and drug 
development (Alenina and Klempin, 2015). Tryptophan hydroxylase 2 deficient (Tph2-/-) mice 
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are selectively depleted of brain serotonin (Alenina et al, 2009). Tph2-/- mice exhibit transient 
early postnatal growth retardation, and modest impairment of sleep and respiration. In 
adulthood, Tph2-/- mice lack maternal care and reveal a less anxious but highly aggressive 
phenotype (Mosienko et al, 2012). Increased aggression and a despair-like state are significant 
of the clinical presentation of depressed patients with reduced serotonin function (i.e., low 5-
hydroxyindoleacetic acid [5-HIAA] levels in cerebrospinal fluid (Mann and Malone, 1997; Placidi 
et al, 2001). Other genetically modified models comprise of overall reduced, or increased 
extracellular levels of serotonin, e.g. mice lacking serotonin transporter. To define mechanisms 
of pharmacotherapy manipulating serotonin remains in research focus since clinical 
improvement can still be accomplished by treatment with SSRI/SSRE in some patients. 
However, to discover the regulators and interactive pathways by which serotonin mediates brain 
function is of equal importance.  
 
Insight comes from studying the contribution of various factors. Previous research has 
focused on serotonin alone. Current theories of the ‘neurobiology of depression’ center on 
structural changes and plasticity dynamics, e.g. impaired adult neurogenesis, dysregulation of 
the hypothalamic pituitary adrenal axis, and altered BDNF signaling. While the biological 
systems are partly intertwined, they might rapidly become uncoupled in disease. BDNF is 
important for the neuronal development. In response to stress, BDNF levels in the hippocampus 
decrease which in turn might negatively regulate neuroplasticity (reviewed in Duman and 
Monteggia, 2006). Antidepressants targeting the serotonin system but also physical exercise 
significantly upregulate BDNF signaling (Adlard et al, 2005; Nibuya et al, 1996)–beneficially 
affecting mood. A few recent studies challenge the monoamine/neurotrophin hypothesis of 
depression by suggesting a direct change in spine density or the ceramide system as 
antidepressant targets (Gulbins et al, 2013; Panayotis et al, 2018). Other candidate molecules 
that might exhibit new drug targets include circulatory factors and signals released by skeletal 
muscles; e.g. vascular endothelial growth factor, the peptide hormone angiotensin (Ang) II and 
Cathepsin B, shown to modulate cell proliferation (Fabel et al, 2003; Moon et al, 2016; Mukuda 
et al, 2014), or vasoactive kinins which can also act as neuropeptides (reviewed in Negraes et 
al, 2015). Excitingly, most of these factors, central and peripheral, are involved in, or modulated 
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by physical exercise that in turn accelerates neuroplasticity of the hippocampus. The interplay 
between these various factors, between serotonin and BDNF, their effects on additional 
responses within the niche, e.g. neurogenesis, and in close proximity to the vasculature, needs 
to be determined and will be discussed in the following. 
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1.2. Objectives    
My research has been inspired by the excitement surrounding adult neurogenesis and the 
hope that a few discrete NSC populations have the power to modify brain function on demand. 
My studies on stem cell biology particularly center on the role of serotonin–a crucial signal in 
the neurogenic niche microenvironment, also involved in antidepressant action–and focus on 
the intersection of changes in behavior such as physical activity and the regulation of 
neurogenesis in the DG. Elucidating basic neurobiological mechanisms of the niche, the effects 
mediated by physical activity, and targeting of central and peripheral signaling pathways (e.g. 
the novel candidate molecule BDNF, and circulatory factors), could lead to potent strategies to 
restore neurogenesis in people with low or inactive brain serotonin, such as in major depression.  
 
By employing a combination of genetic tools and behavioral paradigms the following 
research provides insight into  
 
i) principles of lineage progression of newly born cells in the hippocampus 
ii) the effects of physical exercise on neurobiological mechanisms  
iii) the interplay of serotonin and BDNF under physiological conditions, and how they 
might become uncoupled in disease  
iv) targeting of novel signaling pathways that support neuronal development as 
potential therapeutic alternative. 
 





2. Original research  
 
2.1. Lineage-Instruction Factors of the Neurogenic Niche 
 The approach to drive fate de novo from stem and non-stem cells of the (diseased) brain 
independently of the use of embryonic or induced pluripotent stem cell (iPSC) replacement is of 
particular clinical significance. This potential therapeutic strategy of fate respecification could 
avoid immunogenicity and time grafting exogenous cells. The most attractive approach appears 
to be direct in vivo reprogramming of resident neural cells to induce a neuronal fate (Gascon et 
al, 2016; Klempin et al, 2017). Knowledge can be gained from studying neurogenic niches 
whose innately regenerative capacity is distinguished from non-neurogenic or glial regions of 
the adult brain. Set in a microenvironment of factors and signaling that dictate the rate and type 
of cells developed, NSCs retain fate plasticity and respond to stimuli that foster neurogenesis.  
 The transcription factors and lineage-related genes Olig2 and Pax6 participate in the 
progression from type-1 stem cells to mature neurons in the DG, and manipulating their activity 
can direct the outcome of neurogenesis. 
 
The following abstract is from the original research article:  
“Klempin F, Marr RA, Peterson DA (Modification of pax6 and olig2 expression in adult 
hippocampal neurogenesis selectively induces stem cell fate and alters both neuronal and glial 




“The generation of new neurons in the mammalian hippocampus continues 
throughout life, and lineage progression is regulated by transcription factors, 
local cues, and environmental influences. The ability to direct stem/progenitor 
cell fate in situ may have therapeutic potential. Using an in vivo retroviral delivery 
and lineage tracing approach, we compare the lineage-instruction factors, Pax6  
  12 
and Olig2, and demonstrate that both participate in regulation of adult 
hippocampal neurogenesis in adult rats. We show that overexpression of the 
proneuronal factor  Pax6 pushes neuronal precursor cells to early maturation and 
increases the frequency of neuronal phenotypes. However, Pax6 overexpression 
results in no net increase in neurogenesis at 3 weeks. Blocking of Olig2 function 
reduces and slows neuronal commitment and differentiation and decreases net 
neurogenesis. Altering expression of both factors also changes gliogenesis. Our 
results establish that Pax6 decreases the number of Neuron-Glia 2 progenitor 
cells and prevents oligodendrocyte lineage commitment, while repression of Olig2 
results in an expanded astrocytic lineage. We conclude that selectively modifying 
transcriptional cues within hippocampal progenitor cells is sufficient to induce a 
cell fate switch, thus altering the neurogenesis–gliogenesis ratio. In addition, our 
data show the competence of multiple progenitor lineages to respond divergently 
to the same signal. Therefore, directing instructive cues to select phenotype and 
developmental stage could be critical to achieve precise outcomes in cell genesis. 
Further understanding the regulation of lineage progression in all progenitor 
populations within the target region will be important for developing therapeutic 
strategies to direct cell fate for brain repair.” 
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2.2. Serotonin Transduces Physical Activity into Precursor Cell Proliferation  
 In addition to cell-autonomous molecules and transcription factors, the neurogenic niche 
consists of signaling mediated by neurotransmitters, growth and neurotrophic factors. Serotonin 
crucially contributes to the hippocampus’ capacity for adult neurogenesis, and has been 
intensely studied using pharmacological depletion or receptor targeting approaches (Brezun 
and Daszuta, 2000; Diaz et al, 2013; Klempin et al, 2010). Another pro-neurogenic stimulus is 
physical exercise, identified to strongly increase the number of proliferating cells in the DG (van 
Praag et al, 1999), filling up the niche’s reservoir of new cells that can be recruited on demand 
into a neuronal fate (Fabel and Kempermann, 2008). 
 In a new and more direct approach, the unique genetic loss-of-function model, Tph2-/- 
mice (Alenina et al, 2009), was employed to study adult neurogenesis, and the effects of 
exercise on precursor cell proliferation in the absence of brain serotonin. 
 
The following abstract is from the original research article:  
“Klempin F*, Beis D*, Mosienko V, Kempermann G, Bader M, Alenina N (Serotonin is required 
for exercise-induced adult hippocampal neurogenesis. J Neurosci 33:8270-8275.2013; doi:  
https://doi.org/10.1523/JNEUROSCI.5855-12.2013 
*F.K. and D.B. contributed equally to this work; F.K. and D.B. designed and performed 
research, and analysed data; F.K. wrote the paper 
Comment in: The importance of serotonin in exercise-induced adult neurogenesis: new 
evidence from Tph2-/- mice. [J Neurosci. 2013] 
 
 
“Voluntary wheel running has long been known to induce precursor cell 
proliferation in adult hippocampal neurogenesis in rodents. However, 
mechanisms that couple activity with the promitotic effect are not yet fully 
understood. Using tryptophan hydroxylase (TPH) 2 deficient (Tph2-deficient) 
mice that lack brain serotonin, we explored the relationship between serotonin 
signaling and exercise-induced neurogenesis. Surprisingly, Tph2-deficient 
mice exhibit normal baseline hippocampal neurogenesis but impaired activity-  
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induced proliferation. Our data demonstrate that the proproliferative effect of 
running requires the release of central serotonin in young-adult and aged 
mice. Lack of brain serotonin further results in alterations at the stage of Sox2-
positive precursor cells, suggesting physiological adaptations to changes in 
serotonin supply to maintain homeostasis in the neurogenic niche. We 
conclude that serotonin plays a direct and acute regulatory role in activity-
dependent dependent hippocampal neurogenesis. The understanding of 
exercise-induced neurogenesis might offer preventive but also therapeutic 
opportunities in depression and age-related cognitive decline.” 
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2.3. The Interplay between Brain Serotonin and BDNF Signaling  
The various signaling molecules of the neurogenic niche collaborate with, and may 
compensate for the lack of the other. Particularly exciting is the observation that BDNF may be 
a compensatory target for reinvigorating depression-associated loss of neurogenesis. BDNF is 
the most abundant neurotrophin in the DG, and crucially involved in synaptic plasticity and in 
the generation and survival of newborn neurons (Ferres-Coy et al, 2013; Mattson et al, 2004). 
Numerous basic studies have reported decreased BDNF levels in the hippocampus in response 
to diverse stress conditions (Duman and Monteggia, 2006). Furthermore, SSRI-induced 
increases in serum BDNF have been detected in rodents (Nibuya et al, 1996) and similarly in 
depressed patients (Molendijk et al, 2011). Conversely, changes in serotonin neurotransmission 
may be induced by BDNF (Benmansour et al, 2008). 
The next two studies examine the interplay of serotonin and BDNF, in particular as it 
relates to the effects of additional pro-/anti-depressive stimuli, e.g. adult neurogenesis.  
 
 
2.3.1. Lack of Brain Serotonin Is Compensated by Alterations in BDNF Level  
BDNF signaling could be relevant to mechanisms of antidepressant treatment targeting 
the serotonin system. Using two powerful genetic animal models of altered central serotonin 
signaling, this study determines and compares protein levels of the neurotrophic factor in 
different brain areas by ELISA technique. 
 
The following abstract is from the original research article:  
“Kronenberg G, Mosienko V, Gertz K, Alenina N, Hellweg R, Klempin F (Increased brain-
derived neurotrophic factor (BDNF) protein concentrations in mice lacking brain serotonin. Eur 
Arch Psychiatry Clin Neurosci. 2016 Apr;266(3):281-4; doi:  
https://link.springer.com/article/10.1007/s00406-015-0611-3 
“The interplay between BDNF signaling and the serotonergic system remains 
incompletely understood. Using a highly sensitive enzyme-linked 
immunosorbent assay, we studied BDNF concentrations in hippocampus and  
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cortex of two mouse models of altered serotonin signaling: tryptophan 
hydroxylase (Tph)2-deficient (Tph2-/-) mice lacking brain serotonin and 
serotonin transporter (SERT)-deficient (SERT-/-) mice lacking serotonin re-
uptake. Surprisingly, hippocampal BDNF was significantly elevated in Tph2-/- 
mice, whereas no significant changes were observed in SERT-/- mice. 
Furthermore, BDNF levels were increased in the prefrontal cortex of Tph2-/- 
but not of SERT-/- mice. Our results emphasize the interaction between 
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2.3.2. Serotonin Critically Contributes to the Effects of Electroconvulsive Therapy 
As shown above, my research indicates that serotonin significantly forms the brain’s 
response to physical exercise. In the absence of the neuromodulator, neurotrophic signaling is 
highly active. Serotonin is also a main player in antidepressant action. Electroconvulsive therapy 
is a very effective treatment for major depression–a serious and highly prevalent mental 
disorder. The following study examines whether serotonin is critically involved in brain 
responses to electroconvulsive seizure, namely the induction of adaptive responses such as 
increased adult neurogenesis and increased BDNF signaling.  
 
The following abstract is from the original research article:  
“Kronenberg G, Petermann M, Dormann C, Bader M, Gass P, Hellweg R, Klempin F (Brain 
serotonin critically contributes to the biological effects of electroconvulsive seizures. Eur Arch 






“Compounds targeting serotonin (5-HT) are widely used as antidepressants. 
However, the role of 5-HT in mediating the effects of electroconvulsive seizure 
(ECS) therapy remains undefined. Using Tph2-/- mice depleted of brain 5-HT, 
we studied the effects of ECS on behavior and neurobiology. ECS significantly 
prolonged the start latency in the elevated O-Maze test, an effect that was 
abolished in Tph2-/- mice. Furthermore, in the absence of 5-HT, the ECS-
induced increase in adult neurogenesis and in brain-derived neurotrophic 
factor signaling in the hippocampus were significantly reduced. Our results 
indicate that brain 5-HT critically contributes to the neurobiological responses 
to ECS.” 
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2.4. Elucidating the Peripheral Signals that Regulate Neuroplasticity   
While serotonin activity in brain function is becoming understood, peripheral signals that 
might promote neurogenesis or cause the pro-mitotic effect of physical activity are less explored 
but have remarkable clinical potential. In the DG, soluble factors released by surrounding niches 
such as the vasculature participate in modulation of the proliferative phase, and are also 
abundant in blood circulation. To mechanistically link vascular biology with the neurologic effects 
of serotonin, running-induced cell proliferation was studied in transgenic animal models for 1) 
the renin-angiotensin system (RAS) and for 2) vasoactive kinin peptides (e.g. bradykinin). Both 
the Ang-converting enzyme (ACE) 2–the principal regulatory enzyme of the RAS–and 
bradykinin, important mediators of cardiovascular homeostasis, are expressed in regions of the 
adult brain, particularly in the hippocampus (Chen et al, 2000; Doobay et al, 2007; Shughrue et 
al, 2003). 
Two studies below investigate the role of 1) ACE2 in serotonin levels, and 2) ACE2 and 
bradykinin B2 receptor (B2R) and B1 receptor (B1R) in physical exercise and adult 
neurogenesis.   
 
 
2.4.1. ACE2 as Novel Factor in Serotonin Metabolism and Neurogenesis  
As the principal enzyme of the main humoral system in the body, ACE2 regulates 
cardiovascular homeostasis by controlling the transition from Ang II to Ang-(1-7) which causes 
vasodilation and anti-inflammation (Santos et al, 2013). Recent studies attribute RAS-
independent functions to ACE2 as it also plays a role in the absorption of dietary neutral amino 
acids in the gut, e.g. of L-tryptophan (Trp) (Singer et al, 2012), the serotonin precursor. Given 
that altered Trp levels affect serotonin synthesis, the ACE2 enzyme could modulate brain Trp, 
and serotonin levels, that indirectly affect neurogenesis. 
 
The following abstract is from the original research article:  
“Klempin F, Mosienko V, Matthes S, Villela DC, Todiras M, Penninger JM, Bader M, Santos 
RAS, Alenina N (Depletion of Angiotensin-converting enzyme 2 reduces brain serotonin and 
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impairs the running-induced neurogenic response. Cell Mol Life Sci. 2018 Oct;75(19):3625-
























“Physical exercise induces cell proliferation in the adult hippocampus in rodents. 
Serotonin (5-HT) and angiotensin (Ang) II are important mediators of the pro-
mitotic effect of physical activity. Here, we examine precursor cells in the adult  
brain of mice lacking angiotensin-converting enzyme (ACE) 2, and explore the 
effect of an acute running stimulus on neurogenesis. ACE2 metabolizes Ang II 
to Ang-(1-7) and is essential for the intestinal uptake of tryptophan (Trp), the 5-
HT precursor. In ACE2-deficient mice, we observed a decrease in brain 5-HT 
levels and no increase in the number of BrdU-positive cells following exercise. 
Targeting the Ang II/AT1 axis by blocking the receptor, or experimentally 
increasing Trp/5-HT levels in the brain of ACE2-deficient mice, did not rescue 
the running-induced effect. Furthermore, mice lacking the Ang-(1-7) receptor, 
Mas, presented a normal neurogenic response to exercise. Our results identify 
ACE2 as a novel factor required for exercise-dependent modulation of adult 
neurogenesis and essential for 5-HT metabolism.” 
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2.4.2. Bradykinin as Neuropeptide in Activity-Dependent Cell Proliferation  
 Vasoactive kinin peptides regulate blood pressure and control inflammatory processes by 
primarily causing endogenous vasodilation. Recent studies show that they also function in the 
brain, adding novel actions to kinins as neuropeptides. Particularly, bradykinin is involved in 
glutamate signaling in spinal cord (Kohno et al, 2008), and in cell proliferation and fate choice 
towards neurons in vitro (Nascimento et al, 2015; Trujillo et al, 2012). In disease models, B1R 
and B2R have been shown to participate in the development of temporal lobe epilepsy (Perosa 
et al, 2007; Silva et al, 2008), while in ischemia, B2R is crucial for long-term facilitation of 
angiogenesis (Xia et al, 2006). 
 In the naïve mouse brain, kinin receptor expression as well as adult neurogenesis had not 
been described. Taking advantage of mice depleted in B1R, B2R, or both receptors, this study 
examines the role of kinins as possible neuropeptides in the unchallenged brain, and following 
physical exercise.  
 
The following abstract is from the original research article:  
“Wasinski F, Oliveira Batista R, Bader M, Araujo R, Klempin F (Bradykinin B2 receptor is 
important in running-induced neurogenesis in the adult mouse hippocampus Brain Struct Funct. 




“Physical exercise is a strong external effector that induces precursor cell 
proliferation in the adult mouse hippocampus. Research into mechanisms has 
focused on central changes within the hippocampus and we have established 
that serotonin is the signaling factor that transduces physical activity into adult 
neurogenesis. Less focus has been given on potential peripheral signals that 
may cause pro-mitotic running effects. Vasoactive kinin peptides are important 
for blood pressure regulation and inflammatory processes to maintain 
cardiovascular homeostasis. Acting via the two receptors termed B1 (B1R) and 
B2R, the peptides also function in the brain. In particular, studies attribute B2R  
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a role in cell proliferation and differentiation into neurons in vitro. Here, we 
determined B1R and B2R mRNA expression levels in the adult mouse 
hippocampus and prefrontal cortex in vivo, and in response to running exercise. 
Using mice depleted in either or both receptors, B1-knockout (KO), B2KO and 
B1/2KO we observed changes in running performance overnight and in running 
distances. However, voluntary exercise led to the known pro-mitotic effect in 
the dentate gyrus of B1KO mice while it was attenuated in B2KO accompanied 
by an increase in microglia cells. Our data identify B2R as an important factor 
in running-induced precursor cell proliferation.” 







Stem cells hold promises to cure neuro-psychiatric diseases. With the capacity to 
continuously generate new neurons in the adult, NSCs of the DG constitute an exciting 
endogenous source of multipotent cells that can be deployed to define new drug targets. 
Stem/progenitor cells are responsive to neural activity as well as environmental intervention. 
Dissecting NSC behavior in their particular neurogenic niche, and examining how the various 
signaling factors direct lineage progression is crucial in designing cell-specific therapeutics or 
to repair damaged brain tissue. My research on 1) ectopic-induced neurogenesis using a single 
transcription factor, 2) activity-dependent changes in neuroplasticity, and 3) elucidating the role 
of serotonin and novel peripheral cues, contributes to the understanding of how adult 
neurogenesis is regulated. In addition, my work clearly shows the importance of serotonin as a 
key player in antidepressant action. Serotonin not only modulates neuron replacement but also 
induces additive stimuli that are important for the healthy brain and in drug action.   
 
In the decades after the discovery of adult neurogenesis, numerous studies have 
investigated principal biological processes, and the contribution of newly generated cells to brain 
plasticity under physiological conditions (reviewed in Toda et al, 2019). Recent studies aim to 
elucidate the role of adult-born neurons in the diseased brain. Accumulating evidence from 
rodent models reveals that decreased neurogenesis strongly correlates with impaired cognitive 
performance and mood disorders. Thereby, changes in cell survival or cell death often co-occur 
with deregulated neurotrophic and neurotransmitter signaling. In turn, physical exercise and 
antidepressant treatment upregulate intrinsic factors, cell proliferation and differentiation in 
animal models; and lead to clinical improvement in patients. This is possible since immature 
and mature neurons in the rodent DG differ from adult granule cells in their electrophysiological 
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properties and transient expression pattern (Toni and Schinder, 2015), which makes them 
preferably affective to stimuli. 
 
Physical exercise is a very strong and extensively studied external stimulus promoting 
neuroplasticity. Voluntary running increases the number of precursor cells in the SGZ, but also 
enhances cell proliferation in the newly discovered stem cell niche of the hypothalamus (Klein 
et al, 2019) and the number of Neuron-glia2 (NG2) precursor cells in the amygdala (Ehninger 
et al, 2011). Expanding the pool of glial cells may be particularly important in demyelinating 
diseases, while enhancing neurogenesis is anticipated following stroke, or in neurodegenerative 
and psychiatric disorders. My research established that the neurogenic regulatory capacity of 
physical exercise is mediated through central serotonin (Klempin et al, 2013). Furthermore, 
circulatory factors, e.g. ACE2 or bradykinin, participate in the pro-mitotic effect of running 
(Klempin et al, 2018; Wasinski et al, 2018). These discoveries point to a confluence of signals 
whereby physical activity co-regulates the vascular and neurogenic homeostasis of the brain. 
In particular, the newly identified pathways have potential as a target for modulation of 
neuroplasticity alone or to augment physical exercise in the treatment of mood disorders. In 
humans, both body and brain benefit from activity, and recent studies sought to identify 
molecules that mimic the system level effects of exercise in the brain. Indeed, factors involved 
in energy metabolism secreted by skeletal muscle, or dietary supplements, are capable to 
stimulate cellular targets in the DG (Agudelo et al, 2014; Kobilo et al, 2011; Moon et al, 2016). 
Furthermore, central regulation alone can yield exercise-like effects ameliorating cognition in an 
animal model of AD, e.g. combined elevation of type-2b/3 cell numbers and BDNF levels; 
thereby changes in brain plasticity were mediated by cell-autonomous, autocrine action of BDNF 
(Choi et al, 2018). 
 
My studies of genetically modified mouse models support the importance of brain 
serotonin in adult neurogenesis, and contribute to the understanding of linked mechanisms 
implicated in the etiology of depression, e.g. BDNF signaling (Kronenberg et al, 2015; 
Kronenberg et al, 2018). Specifically, brain serotonin and BDNF interact to maintain 
homeostasis in that loss of the neurotransmitter promotes neurotrophic signaling in the 
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hippocampus. However, using developmental mouse models with altered serotonin levels alone 
one cannot discriminate between compensatory processes provoked by life-long depletion and 
phenotypes induced by serotonin per se. My current work employs new genetic tools where 
serotonin levels can be acutely depleted, or repeatedly stimulated, which recapitulate the human 
condition more adequately (Tph2Tph2-iCre conditional Tph2-knockout mouse and TetO-shTph2 
inducible transgenic rats). Potentially, acute changes in behavior, neurogenesis, or BDNF levels 
following impaired serotonin signaling can be explored, in addition to acute relapses such as 
those that may follow cessation of SSRIs in patients. This work will yield further important 
insights into the role of serotonin in the etiology and pathogenesis of affective syndromes and 
depression that might aid the development of new therapeutic targets.  
 
Psychiatric disorders are polygenic, induced by many different genetic variants (reviewed 
in Sullivan and Geschwind, 2019). Depression, in particular, is a comorbidity trait also observed 
in vascular diseases such as dementia, stroke, and myocardial infarction. To innovate and 
improve pharmacotherapy, the discovery of pathways that regulate cell birth, and the 
mechanistic link of physical activity and neural circuits that control neurogenesis in normal brain 
and disease is of importance. Studying transgenic animals is one approach; by using mouse 
models of the serotonin system as well as of peptide hormones of the vasculature, my data 
reveal a correlation between system level effects and neurobiology. Newly developed 
technologies embrace optogenetics and single cell sequencing. Optogenetics, in particular, 
allows the activation of brain circuits. Using another transgenic model of serotonin signaling, 
Tph2-ChR2-eYFP mice, enables 1) to observe projections and wiring from raphe nuclei to DG, 
and 2) recordings from granule cells in the hippocampus that might indicate direct afferent 
targets from serotonin neurons, and a potential functional interaction between the 
neurotransmitter and stem/progenitor cells. Furthermore, the optogenetic setup can be used to 
mimic physical exercise by continues stimulation of the above circuitry. Imaging and anatomical 
reconstruction of serotonin fiber pathways will reveal a subset of varicose innervation that 
specifically regulates the neurogenic niche.  
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Novel methods to define mechanisms and treatment strategies include the generation of 
neurons de novo by directed lineage progression of endogenous stem cells together with 
metabolic reprogramming (Gascon et al, 2016; Klempin et al, 2017) or cell fate respecification 
in vitro. My research showed that selectively modifying transcriptional cues in progenitor cells 
of the DG is sufficient to induce a cell fate switch (Klempin et al, 2012). Using iPSCs to achieve 
a specific phenotype could be used as cell repair strategy in neurodegenerative disorders such 
as Parkinson’s disease, where dopaminergic neurons are lost. In rather dispersed disorders 
such as AD, where neuron loss is a consequence of pathogenic proteins, or in trauma and upon 
injury, restoring brain tissue beyond one particular cell phenotype is required. Recently, human-
iPSC-based approaches have been developed to distinguish and model the patient-specific 
complexity of major depression (reviewed in Hoffman et al, 2019). Therefore, aiming at cellular 
and plasticity-regulating genes together with local cues and signaling factors as therapeutic 
strategy might be effective to improve mood.  
 
Adult neurogenesis critically contributes to brain plasticity. My studies have shown that 
targeting neurogenesis in rodents is an important mechanism of antidepressant action. Adult-
born neurons might also promote human health. However, identifying the role of neuroplasticity 
in the adult human brain and the relevance in disease has been challenging. Although numerous 
studies demonstrate that the mammalian brain has the capacity to continuously generate new 
neurons, primarily shown by 3H-thymidine labeling and different markers of lineage progression, 
there are methodological limitations to the detection of newborn cells in the rather large human 
brain (Kempermann et al, 2018). Besides, a recent study casts doubt on whether neurogenesis 
persists in the adult human hippocampus. Using post-mortem tissue, Alvarez-Buylla and 
colleagues were unable to detect newborn neurons in the DG of young-adult and adult patients 
(Sorrells et al, 2018). In contrast, subsequent publications by others are in support of the 
existence of human neurogenesis in aging (Boldrini et al, 2018; Moreno-Jiménez et al, 2019; 
Tobin et al, 2019). They have combined human brain samples obtained under highly 
standardized conditions with innovative tissue processing and eloquent control experiments. 
The studies have identified a high number of neural progenitor cells (Boldrini et al, 2018; Tobin 
et al, 2019) and immature neurons in healthy brain tissue compared with pathological samples, 
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where numbers progressively declined (Moreno-Jiménez et al, 2019). The studies for vs. 
against human neurogenesis disagree in their conclusions based on the (non)detection of 
marker expression. The discrepancy is most likely due to methodological differences in tissue 
processing, duration of fixation, fixative and use of anatomical references that define visibility 
and detection of neuronal lineage markers at different ages and time points. Future research 
requires the incorporation of more and novel markers of the neural lineage recently established 
in rodent models. Nonetheless, the latest evidences suggest progenitor cells persist in the adult 
human brain that play a role in neuroplasticity; yet, it needs to be determined whether they 
contribute to repair as well. My research adds to the understanding of antidepressant action, 
and especially demonstrates the mechanistically linked effort of serotonin, the vasculature and 
physical activity to regulate cell birth. This is not only important for cognitive improvement or 
treatment of mood disorders, but also relevant in ischemia as response to ectopic challenges. 
In most parts of the brain, neurogenesis lacks a niche because environmental signals are shut 
off. Knowledge gained from dissecting NSC behavior and signaling pathways in the defined 
neurogenic niche microenvironment could potentially be applied to the entire brain and 












Self-repair of the adult brain is limited – most diseases lack effective therapy. In order to 
better understand how a regenerative response can be achieved, studying mechanisms 
shaping the neurogenic niche, from environmental factors to intrinsic signaling, is of 
significance. My work highlights the enormous plasticity of the CNS and the crucial role of 
serotonin in affecting the behavior of neural stem/progenitor cells. It allows important insights 
into antidepressant strategies that involve physical activity, adult neurogenesis, BDNF, and 
signals of the vascular niche. Future research will have to elucidate the systemic cues and 
targets that regulate neuroplasticity and how they become deregulated in disease. It remains to 
be seen how they will contribute to the development of novel therapies and biomarkers for 
cognitive disorders. 
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